LIPA and metabolic dysfunction-associated steatotic liver disease: The strong 0.9 ppm signal arising from cholesterol moieties facilitates detection of CE by 1H spectroscopy, and the markedly different and characteristic pattern of lipid proton resonances in the 1H spectrum from LAL deficient subjects compared to the NAFLD group represents a biomarker with potential for non-invasive diagnosis and monitoring of disease progression.